• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3685

10-year publication summary

245
221
293
262
262
293
300
320
349
207
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Deciphera Pharmaceuticals, LLC
223
68
Novartis AG
10850
59
Incyte Corporation
1024
49
F. Hoffmann-La Roche AG
7921
43
Immunomedics, Inc.
259
42
Bristol-myers Squibb Company
4893
41
Merck Sharp & Dohme LLC
3741
40
Merck Patent GmbH
5823
37
Bayer Pharma AG
1047
35
Boehringer Ingelheim International GmbH
4648
34
Hoffmann-La Roche Inc.
3422
27
Gilead Sciences, Inc.
2037
27
Pfizer Inc.
3381
26
Takeda Pharmaceutical Company Limited
2709
26
Shenzhen HighTide Biopharmaceutical, Ltd.
57
26
Bayer AG
3331
25
Pliant Therapeutics, Inc.
65
25
Genentech, Inc.
3980
23
Merck Sharp & Dohme Corp.
2190
22
Glaxosmithkline Intellectual Property Development Limited
761
22
Other owners 2988